 |
인쇄하기
취소
|
New drug pricing reform will hurt leading pharmaceutical firms
A report released on November 11 said Korea's eight leading drug makers could lose up to 765.5 billion won in revenue and 750.8 billion won in operating income by 2014 if the government’s drug price cut plan goes into effect starting next April.
The eight drug makers include Dong-A, Green Cross, Hanmi, Yuhan, Daewoon, Chong Kun Dang, JW Pharmaceutical and Ildong.
The estimated losses are ...
The eight drug makers include Dong-A, Green Cross, Hanmi, Yuhan, Daewoon, Chong Kun Dang, JW Pharmaceutical and Ildong.
The estimated losses are ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.